Lithium Carbonate
LITHIUM CARBONATE Tablets USP, LITHIUM CARBONATE Capsules USP, LITHIUM Oral Solution USP
Approved
Approval ID
e2aa1b69-8f0a-4632-ba08-ca3d7e5e6de8
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Mar 10, 2014
Manufacturers
FDA
TYA Pharmaceuticals
DUNS: 938389038
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lithium Carbonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code64725-2527
Application NumberNDA017812
Product Classification
M
Marketing Category
C73594
G
Generic Name
Lithium Carbonate
Product Specifications
Route of AdministrationORAL
Effective DateMarch 10, 2014
FDA Product Classification
INGREDIENTS (9)
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
LITHIUM CARBONATEActive
Quantity: 300 mg in 1 1
Code: 2BMD2GNA4V
Classification: ACTIB
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT